Literature DB >> 35507298

Frequently Used Allopathic and Traditional Medicine for COVID-19 Treatment and Feasibility of Their Integration.

Aditya Upadhayay1, Gopal Patel2, Dharm Pal3, Awanish Kumar4.   

Abstract

To date, no satisfactory treatment for COVID-19 is available. This review reported few recent updates regarding the drugs (allopathy/traditional medicines) used for the treatment of COVID-19 concerning clinical studies. Content of the article spotlight the contribution of allopathic and Ayurvedic drugs to the scientific basis for utilization as a potential therapy against COVID-19 infection and provide new insights on the integration of allopathy and traditional medicine. It advocated the combination of these two systems of treatment will ascertain their integrations, and there would be a good possibility and scope for developing a model of integration in the management of COVID-19. Provided discussion may help researchers, physicians, and healthcare policymakers to encourage for effective and integrated use of allopathic and Ayurvedic medicines to control the COVID-19 pandemic more effectively.
© 2022. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  COVID-19; allopathy; integration; promising therapy; traditional medicine

Year:  2022        PMID: 35507298      PMCID: PMC9065245          DOI: 10.1007/s11655-021-3512-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   2.626


  40 in total

Review 1.  New respiratory viral infections.

Authors:  Tuomas Jartti; Laura Jartti; Olli Ruuskanen; Maria Söderlund-Venermo
Journal:  Curr Opin Pulm Med       Date:  2012-05       Impact factor: 3.155

2.  Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus.

Authors:  Snawar Hussain; Ji'an Pan; Yu Chen; Yalin Yang; Jing Xu; Yu Peng; Ying Wu; Zhaoyang Li; Ying Zhu; Po Tien; Deyin Guo
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.

Authors:  Y Guan; B J Zheng; Y Q He; X L Liu; Z X Zhuang; C L Cheung; S W Luo; P H Li; L J Zhang; Y J Guan; K M Butt; K L Wong; K W Chan; W Lim; K F Shortridge; K Y Yuen; J S M Peiris; L L M Poon
Journal:  Science       Date:  2003-09-04       Impact factor: 47.728

4.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

Review 5.  An overview of COVID-19.

Authors:  Yu Shi; Gang Wang; Xiao-Peng Cai; Jing-Wen Deng; Lin Zheng; Hai-Hong Zhu; Min Zheng; Bo Yang; Zhi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2020-05-08       Impact factor: 3.066

6.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.

Authors:  Jasper Fuk-Woo Chan; Kin-Hang Kok; Zheng Zhu; Hin Chu; Kelvin Kai-Wang To; Shuofeng Yuan; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2020-01-28       Impact factor: 7.163

7.  COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies.

Authors:  Vrishali S Salian; Jessica A Wright; Peter T Vedell; Sanjana Nair; Chenxu Li; Mahathi Kandimalla; Xiaojia Tang; Eva M Carmona Porquera; Krishna R Kalari; Karunya K Kandimalla
Journal:  Mol Pharm       Date:  2021-01-19       Impact factor: 4.939

Review 8.  Emerging coronaviruses: Genome structure, replication, and pathogenesis.

Authors:  Yu Chen; Qianyun Liu; Deyin Guo
Journal:  J Med Virol       Date:  2020-02-07       Impact factor: 2.327

9.  Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.

Authors:  Lisheng Wang; Yiru Wang; Dawei Ye; Qingquan Liu
Journal:  Int J Antimicrob Agents       Date:  2020-03-19       Impact factor: 5.283

10.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

View more
  1 in total

Review 1.  Antibacterial activities of seven ethnomedicinal plants from family Annonaceae.

Authors:  Diannita Harahap; Sarah Niaci; Vivi Mardina; Bintang Zaura; Intan Qanita; Agnia Purnama; Kana Puspita; Diva Rayyan Rizki; Muhammad Iqhrammullah
Journal:  J Adv Pharm Technol Res       Date:  2022-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.